792 related articles for article (PubMed ID: 16200598)
1. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
Koenders MI; Kolls JK; Oppers-Walgreen B; van den Bersselaar L; Joosten LA; Schurr JR; Schwarzenberger P; van den Berg WB; Lubberts E
Arthritis Rheum; 2005 Oct; 52(10):3239-47. PubMed ID: 16200598
[TBL] [Abstract][Full Text] [Related]
2. Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production.
Abdollahi-Roodsaz S; Joosten LA; Helsen MM; Walgreen B; van Lent PL; van den Bersselaar LA; Koenders MI; van den Berg WB
Arthritis Rheum; 2008 Dec; 58(12):3753-64. PubMed ID: 19035506
[TBL] [Abstract][Full Text] [Related]
3. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
[TBL] [Abstract][Full Text] [Related]
4. Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1.
Koenders MI; Lubberts E; Oppers-Walgreen B; van den Bersselaar L; Helsen MM; Kolls JK; Joosten LA; van den Berg WB
Arthritis Rheum; 2005 Mar; 52(3):975-83. PubMed ID: 15751058
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.
Lubberts E; Joosten LA; van Den Bersselaar L; Helsen MM; Bakker AC; van Meurs JB; Graham FL; Richards CD; van Den Berg WB
J Immunol; 1999 Oct; 163(8):4546-56. PubMed ID: 10510398
[TBL] [Abstract][Full Text] [Related]
6. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
7. T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: crucial role of both interleukin-1beta and interleukin-17.
Joosten LA; Abdollahi-Roodsaz S; Heuvelmans-Jacobs M; Helsen MM; van den Bersselaar LA; Oppers-Walgreen B; Koenders MI; van den Berg WB
Arthritis Rheum; 2008 Jan; 58(1):98-108. PubMed ID: 18163514
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis.
van Lent PL; Grevers LC; Blom AB; Arntz OJ; van de Loo FA; van der Kraan P; Abdollahi-Roodsaz S; Srikrishna G; Freeze H; Sloetjes A; Nacken W; Vogl T; Roth J; van den Berg WB
Arthritis Rheum; 2008 Dec; 58(12):3776-87. PubMed ID: 19035520
[TBL] [Abstract][Full Text] [Related]
9. Reduction of arthritis severity in protease-activated receptor-deficient mice.
Yang YH; Hall P; Little CB; Fosang AJ; Milenkovski G; Santos L; Xue J; Tipping P; Morand EF
Arthritis Rheum; 2005 Apr; 52(4):1325-32. PubMed ID: 15818676
[TBL] [Abstract][Full Text] [Related]
10. Local interleukin-12 gene transfer promotes conversion of an acute arthritis to a chronic destructive arthritis.
Joosten LA; Heuvelmans-Jacobs M; Lubberts E; van de Loo FA; Bakker AC; Helsen MM; Richards CD; van den Berg WB
Arthritis Rheum; 2002 May; 46(5):1379-89. PubMed ID: 12115246
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis.
Koenders MI; Marijnissen RJ; Devesa I; Lubberts E; Joosten LA; Roth J; van Lent PL; van de Loo FA; van den Berg WB
Arthritis Rheum; 2011 Aug; 63(8):2329-39. PubMed ID: 21520013
[TBL] [Abstract][Full Text] [Related]
12. Different amplifying mechanisms of interleukin-17 and interferon-gamma in Fcgamma receptor-mediated cartilage destruction in murine immune complex-mediated arthritis.
Grevers LC; van Lent PL; Koenders MI; Walgreen B; Sloetjes AW; Nimmerjahn F; Sjef Verbeek J; van den Berg WB
Arthritis Rheum; 2009 Feb; 60(2):396-407. PubMed ID: 19180490
[TBL] [Abstract][Full Text] [Related]
13. Systemic viral interleukin-10 gene delivery prevents cartilage invasion by human rheumatoid synovial tissue engrafted in SCID mice.
Jorgensen C; Apparailly F; Canovas F; Verwaerde C; Auriault C; Jacquet C; Sany J
Arthritis Rheum; 1999 Apr; 42(4):678-85. PubMed ID: 10211881
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis.
van Lent PL; Grevers L; Blom AB; Sloetjes A; Mort JS; Vogl T; Nacken W; van den Berg WB; Roth J
Ann Rheum Dis; 2008 Dec; 67(12):1750-8. PubMed ID: 18055478
[TBL] [Abstract][Full Text] [Related]
15. IL-32gamma and Streptococcus pyogenes cell wall fragments synergise for IL-1-dependent destructive arthritis via upregulation of TLR-2 and NOD2.
Heinhuis B; Koenders MI; van de Loo FA; van Lent PL; Kim SH; Dinarello CA; Joosten LA; van den Berg WB
Ann Rheum Dis; 2010 Oct; 69(10):1866-72. PubMed ID: 20472585
[TBL] [Abstract][Full Text] [Related]
16. Joint inflammation and chondrocyte death become independent of Fcgamma receptor type III by local overexpression of interferon-gamma during immune complex-mediated arthritis.
Nabbe KC; Boross P; Holthuysen AE; Sloëtjes AW; Kolls JK; Verbeek S; van Lent PL; van Den Berg WB
Arthritis Rheum; 2005 Mar; 52(3):967-74. PubMed ID: 15751061
[TBL] [Abstract][Full Text] [Related]
17. Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor alpha-independent mouse model.
Plater-Zyberk C; Joosten LA; Helsen MM; Koenders MI; Baeuerle PA; van den Berg WB
Ann Rheum Dis; 2009 May; 68(5):721-8. PubMed ID: 18495731
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of disease progression by a novel retinoid antagonist in animal models of arthritis.
Beehler BC; Hei YJ; Chen S; Lupisella JA; Ostrowski J; Starrett JE; Tortolani D; Tramposch KM; Reczek PR
J Rheumatol; 2003 Feb; 30(2):355-63. PubMed ID: 12563696
[TBL] [Abstract][Full Text] [Related]
19. Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation.
van de Loo FA; Arntz OJ; van Enckevort FH; van Lent PL; van den Berg WB
Arthritis Rheum; 1998 Apr; 41(4):634-46. PubMed ID: 9550472
[TBL] [Abstract][Full Text] [Related]
20. Effect of NOS2 gene deficiency on the development of autoantibody mediated arthritis and subsequent articular cartilage degeneration.
Kato H; Nishida K; Yoshida A; Takada I; McCown C; Matsuo M; Murakami T; Inoue H
J Rheumatol; 2003 Feb; 30(2):247-55. PubMed ID: 12563676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
